Medical Metrics, Inc. Announces Involvement in ReOpen CRS Clinical Trials

May 13, 2024

Copied to clipboard

https://www.einpresswire.com/article/710268304/medical-metrics-inc-announces-involvement-in-reopen-crs-clinical-trials

Medical Metrics, Inc. is proud to have worked with Optinose on their ReOpen clinical trials, which have recently received FDA approval! A heartfelt thank you to all our amazing collaborators, including our dedicated neuroradiologist readers, Key Opinion Leader consultants, and the incredible project personnel on both teams!

Latest Industry News

10640Ortho Publication

Moximed MISHA Knee System for osteoarthritis demonstrates superiority over HTO

MMI is proud to have partnered with Moximed on an FDA-regulated IDE study to investigate the safety and effectiveness of the MISHA Knee System as a treatment option for younger patients with mild to moderate OA.

Learn More

10477News Spine

DiscGenics Announces FDA RMAT Designation

The FDA granted RMAT designation to DiscGenics’ Injectable Disc Cell Therapy for degenerative disc disease.

Learn More

10470News Trials

FDA no longer requires animal tests before human drug trials

A newly signed law permits the FDA to clear a drug for human clinical trials while bypassing animal trials.

Learn More

Let MMI provide insights into your clinical study imaging.

Have questions? We’ll connect you immediately to one of our scientific managers and imaging experts. Your time is precious, and we want to make the most out of it.

error: